Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-639 versus placebo with pregabalin active control in diabetic neuropathic pain
2010-024359-99Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ABT-639 in diabetic polyneuropathy (DPN) (3 arms), sponsored by Abbott Laboratories. Primary endpoint: Weekly mean 24-hour average pain score. Started Apr 2011; status: completed.
02
Drugs
ABT-639
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2010-024359-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024359-99.